The airway epithelium is the primary structural and functional airway barrier and orchestrates innate immunity. Some children may have underlying epi…
Asthma remission has emerged as a potential therapeutic goal. However, definitions of remission have primarily focused on adult populations, with lim…
Asthma affects more than 300 million people worldwide and is frequently associated with other medical conditions in adults, including chronic obstruc…
Researchers developing a world-first treatment that targets an underlying cause of asthma have secured a $499,640 grant from the Future Health, Resea…
Asthma affects > 10% of children in Australia and New Zealand (NZ), with up to 5% of those having severe disease, presenting a management challenge.…
Electronic cigarettes (e-cigarettes) are often perceived to be a less harmful alternative to tobacco cigarettes. Potentially due to this perception,…
Allergic sensitization and reduced ability to respond to viral infections may contribute to virus-induced wheeze and asthma development in young chil…
Early childhood wheeze is a major risk factor for asthma. However, not all children who wheeze will develop the disease. The airway epithelium has be…
Early-life immune development is a critical factor in predicting the risk of childhood respiratory infections, asthma, and poor vaccine responses. Id…